In this special report, eyeforpharma examines the ways pharma can use social media to engage patients, customers, and payers
Pete Gale, head of user experience for Blue Latitude, on the challenge of innovation
Mary Wieder of Arithmos suggests some tips on how pharma should assess potential outsourcing partners
Dr. Andree K. Bates examines the 5 issues that need to be addressed to increase uptake of personalized medicine
Cherie Yates of Siren Interactive examines the Google products and innovations that will affect the paid and organic search strategies of pharma firms
Dr. Andree K. Bates on how to develop launch plans that maximize commercial viability
Milos Graonic, senior vice president at Nielsen, discusses the impact of “activist patients” on pharma
Andrew Tolve outlines the pharma industry’s growing need for local insights and local patient partnerships to gain market access
Craig DeLarge examines how pharma can capitalize on yet another new media trend.
Though the Internet is not quite a mass medium yet, Brazilians are very open to interacting with brands via social media
Paul Cook, analytics consultant with Blue Latitude, on the impact of the EU’s privacy directive on digital marketing and sales tracking
Will Myddelton, user experience consultant with Blue Latitude, on the human side of behavior change
When US marketing as a whole is becoming saturated, the Hispanic community offers potential growth
Why pharma marketing is like directing a feature film
Alex Gochtovtt, principal with Cognizant’s enterprise analytics practice, discusses pharma’s social media opportunities and the importance of data analytics
An interview with Serkan Erkovan of Boehringer Ingelheim.
Ashok Bhaseen, Vice President of Sales & Marketing at Pediapharm reveals how his company establishes trust when engaging KOLs
Peter Mansell reports on how to balance complexity and predictability when forecasting for biologics